HOLLYWOOD, FL—The gap in outcomes between the Eluvia (Boston Scientific) and Zilver PTX (Cook Medical) drug-eluting stents is especially pronounced for diabetic patients being treated for ...
SAN DIEGO, CA—In the first randomized, head-to-head comparison of two drug-eluting stents in patients with femoropopliteal disease, the Eluvia paclitaxel-eluting stent (Boston Scientific) came out ...
The Eluvia stent is designed to release paclitaxel for a 1-year time frame to prevent tissue regrowth that might otherwise block the stented artery. The Food and Drug Administration (FDA) has approved ...
LAS VEGAS and MARLBOROUGH, Mass., Oct. 6, 2021 /PRNewswire/ -- Today, Boston Scientific Corporation (NYSE: BSX) announced positive data for the Eluvia™ Drug-Eluting Vascular Stent System (Eluvia stent ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Boston Scientific Corporation BSX recently announced the receipt of a New Technology Add-on Payment (NTAP) for its Eluvia Drug-Eluting Vascular Stent System from the U.S. Centers for Medicare and ...
SAN DIEGO and MARLBOROUGH, Mass., Sept. 22, 2018 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive 12-month data from the IMPERIAL trial, the first head-to-head drug-eluting ...
JONESBORO, AR (KAIT) - On Tuesday physicians at St. Bernards Medical Center were the first in the state of Arkansas to perform a life-saving surgery. Cardiologists Dr. Max Arroyo and Dr. Ahmed Ahmed ...
Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8297351-boston-scientific-eluvia-drug-eluting-vascular-stent-system ...
Shares of Boston Scientific were slightly up on Monday (about 1.44%), as the Marlborough, Mass.-based company announced it received FDA approval for the Eluvia Drug-Eluting Vascular Stent System. The ...
Regulators in the United States have approved the Eluvia Drug-Eluting Vascular Stent System (Boston Scientific) for the treatment of peripheral artery disease (PAD), based on the ...
Boston Scientific Corporation BSX recently announced the receipt of a New Technology Add-on Payment (NTAP) for its Eluvia Drug-Eluting Vascular Stent System from the U.S. Centers for Medicare and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results